NCT04961905View on ClinicalTrials.gov

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 3, 2022

Primary Completion Date

April 25, 2023

Study Completion Date

May 30, 2023

Conditions
Healthy
Interventions
DRUG

NVP-2002-R1+NVP-2002-R2

NVP-2002-R1 1 tablet, once daily and NVP-2002-R2 1 tablet, once daily

DRUG

NVP-2002

NVP-2002 is a combination of NVP-2002-R1 and NVP-2002\_R2 NVP-2002, 1 tablet, once daily

Trial Locations (1)

54907

Jeonbuk national university hospital, Jeonju

Sponsors

Lead Sponsor

NVP Healthcare
All Listed Sponsors
lead

NVP Healthcare

INDUSTRY